Variant report
Variant | esv3361808 |
---|---|
Chromosome Location | chr1:193254259-193254836 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:193249727..193252720-chr1:193254331..193256682,2 | K562 | blood: | |
2 | chr1:193253060..193255508-chr1:193274779..193276360,2 | MCF-7 | breast: | |
3 | chr1:193251220..193253258-chr1:193254236..193256682,2 | K562 | blood: | |
4 | chr1:193254488..193256138-chr1:193258894..193261172,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141747514 | chr1:193254276-193254277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs573318476 | chr1:193254322-193254323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553009827 | chr1:193254328-193254329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148716305 | chr1:193254347-193254348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183285503 | chr1:193254450-193254451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558925808 | chr1:193254455-193254456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371419889 | chr1:193254553-193254554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544399639 | chr1:193254555-193254556 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560782121 | chr1:193254596-193254597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574466935 | chr1:193254630-193254631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187928043 | chr1:193254634-193254635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150527740 | chr1:193254659-193254660 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532016743 | chr1:193254681-193254682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs193292414 | chr1:193254701-193254702 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565596040 | chr1:193254711-193254712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2244478 | chr1:193254737-193254738 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs551161109 | chr1:193254743-193254744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567800404 | chr1:193254746-193254747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536737191 | chr1:193254751-193254752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547144360 | chr1:193254752-193254753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566855001 | chr1:193254760-193254761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs72740270 | chr1:193254766-193254767 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs369748627 | chr1:193254799-193254800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 21062444 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:193218600-193258200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
2 | chr1:193229000-193254800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr1:193239800-193254600 | Weak transcription | HSMM | muscle |
4 | chr1:193243800-193254400 | Weak transcription | HSMMtube | muscle |
5 | chr1:193243800-193267800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr1:193250200-193257800 | Weak transcription | NHDF-Ad | bronchial |
7 | chr1:193252600-193254600 | Weak transcription | NHLF | lung |
8 | chr1:193252600-193254800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr1:193252600-193256400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
10 | chr1:193252600-193258000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
11 | chr1:193252800-193254800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr1:193252800-193258000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr1:193254400-193254600 | Enhancers | H9 Cell Line | embryonic stem cell |
14 | chr1:193254400-193254600 | Enhancers | HSMMtube | muscle |
15 | chr1:193254600-193255000 | Enhancers | NHLF | lung |
16 | chr1:193254600-193255200 | Enhancers | HSMM | muscle |
17 | chr1:193254800-193255200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |